EDT Spectral Medical Inc
- 0.490
- -0.020-3.92%
Spectral Medical Inc News
Spectral Medical Inc. Announces Results of Annual Meeting of Shareholders
TORONTO, June 07, 2024 (GLOBE NEWSWIRE) -- Spectral Medical Inc. ("Spectral" or the "Company") (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic shock,
Shareholders May Be More Conservative With Spectral Medical Inc.'s (TSE:EDT) CEO Compensation For Now
Spectral Medical Q1 Loss Widens, Says Tigris Trial Enrollment Reaches 106 Patients
Spectral Medical (EDT.TO) said its first quarter loss significantly widened due to higher operating expense. The company, which is developing therapies to treat sepsis, recorded a loss of $4.2 million
Spectral Medical Brief: Loss for the Three-months Ended March 31, 2024 Was $4,160,000 ($0.01 per Share)
07:34 AM EDT, 05/13/2024 (MT Newswires) -- Spectral Medical Brief: Loss for the three-months ended March 31, 2024 was $4,160,000 ($0.01 per share)
Spectral Medical Chair to Retire From the Board of Directors
Spectral Medical Brief: Says Total of 97 Patients Randomized to Date Out of the 150 Total Patients to Be Enrolled in the Tigris Trial
04:27 PM EDT, 03/28/2024 (MT Newswires) -- Spectral Medical Brief: Says Total of 97 patients randomized to date out of the 150 total patients to be enrolled in the Tigris trial
Spectral Medical Announces Fourth Quarter and Fiscal 2023 Results and Provides Corporate Update
Spectral Medical Provides February Tigris Trial Update
Spectral Medical Brief: Baxter to Act as Exclusive Partner to Spectral for 10 Years Following PMX Approval by U.S. FDA
04:01 PM EST, 02/21/2024 (MT Newswires) -- Spectral Medical Brief: Baxter to act as Exclusive partner to Spectral for 10 years following PMX approval by U.S. FDA
Spectral Medical Announces Amendment and Extension of Exclusive Supply and Distribution Agreement With Baxter Healthcare Corporation
Spectral Medical Brief: Announcing "Major Milestone" by Reaching Its Interim Enrollment Target of 90 Patients
07:42 AM EST, 02/15/2024 (MT Newswires) -- Spectral Medical Brief: Announcing "Major Milestone" by Reaching Its Interim Enrollment Target of 90 Patients
Spectral Medical Provides Early February Tigris Trial Update
Spectral Medical Nears Phase 3 Trial Interim Goal
Spectral Medical Provides November Tigris Trial Update
Stocks in Play: Spectral Medical Inc.
Spectral Medical Announces CFO Departure
Sidoti Events, LLC's Virtual November Micro-Cap Conference
Spectral Medical Announces Publication of Tigris Trial Methods Paper and Simulation of Results
Spectral Medical Announces Third Quarter Results and Provides Corporate Update
Spectral Medical Brief: Providing Tigris Trial Update; 76 Patients Enrolled; Emory Healthcare Latest Clinical Site Addition Into the Tigris Trial
08:02 AM EST, 11/07/2023 (MT Newswires) -- Spectral Medical Brief: Providing Tigris Trial Update; 76 patients enrolled; Emory Healthcare latest clinical site addition into the Tigris Trial
